NOI HT941026N0034 BIOFIRE Molecular Assay Analyzer CPT.pdf

Notice of Intent to Sole Source

HT941026N0034

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE PURCHASE ORDER

CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division - West (HCD- W), Echo Branch intends to negotiate and award a firm-fixed price purchase order (PO) contract for the provision of all services, materials, and equipment necessary to provide required analyzer, assays, reagents and consumables for Laboratory Department Naval Hospital Camp Pendleton (NHCP) in accordance with Federal Acquisition Regulation (FAR) 6.302-1 Sole Source acquisitions and FAR 12.102 (a) only one source being available to meet the Government’s needs, to:

BIOFIRE DEFENSE LLC

79 W 4500 S, STE 14

SALT LAKE CITY, UT 84107-2663

UEI: NHMDGM122546

CAGE: 088J2

The North American Industry Classification System (NAICS) code for this requirement is 334516 - Analytical Laboratory Instrument Manufacturing; the business size standard is 1,000 (# of employees). The Product Service Code (PSC) is 6632 - Analysis Instruments, Medical Laboratory Use.

The requirement is for a BIOFIRE Molecular Assay Analyzer Cost Per Test (CPT) contract for one (1) laboratory, molecular assay, infectious microorganism analyzer (device code: 20-802), reagents, annual maintenance coverage, touch base/duplex box/module, and consumables for Naval Hospital (NH) Camp Pendleton. The automated molecular diagnostic laboratory analyzer shall be able to analyze polymerase chain reaction (PCR) samples to identify molecules of microorganisms within various pathogens. The analyzer shall be capable of testing specifically respiratory targets, blood culture targets, and meningitis/encephalitis (ME) targets. The automated molecular diagnostic laboratory analyzer shall be capable of performing at least, but not be limited to, the tests listed below. Tests/Year are listed in the number of kits, which include 30 tests per kit.

TEST DESCRIPTION TESTS/YEAR

Respiratory Panel Assay 180 Blood Culture Identification (BCID 2) 20 Meningitis/Encephalitis Panel Assay (ME) 20

Location: Naval Hospital Camp Pendleton 200 Mercy Circle Camp Pendleton CA 92055-5191

The Delivery Period:

Base Period 04/15/2026 – 09/30/2026 Option Period 1. 10/01/2026 – 09/30/2027 Option Period 2. 10/01/2027 – 09/30/2028 Option Period 3. 10/01/2028 – 09/30/2029 Option Period 4. 10/01/2029 – 09/30/2030 Option Period 5. 10/01/2030 – 04/14/2031

Based on market research and previous acquisition history, it has been determined that Biofire Defense LLC is the only source that can meet the Government’s specialized requirement.

This notice of intent is not a request for competitive proposals, and no solicitation document exists for this requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed six (8.5 x 11 inch) pages using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source purchase order.

If a vendor challenges the basis of this requirement, please email capability statements as a Microsoft Word or Adobe PDF attachment to Denise Bond at denise.d.bond.civ@health.mil and Michelle Sanders at michelle.e.sanders6.civ@health.mil. The closing date for challenges is no later than 10:00 a.m. (Pacific), 19 March 2026.

NO TELEPHONE REQUESTS/OFFERS WILL BE HONORED.

mailto:denise.d.bond.civ@health.mil mailto:michelle.e.sanders6.civ@health.mil